向RACGAP1抑制生长激素的 pituitary adenoma 的生长
Feifan Sun1,2, Chenxing Ji1,2, Xiang Zhou1,2,3
1Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, National Center for Neurological Disorders, Shanghai, 200040, China.
Endocrine
|November 28, 2024
概括
Rac GTPase激活蛋白1 (RACGAP1) 在生长激素垂体腺瘤 (GHPA) 中过度表达. 抑制RACGAP1抑制了瘤生长,确定DB07268是GHPA的潜在治疗剂.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 增长激素垂体腺瘤 (GHPA) 是一种显著的垂体腺瘤 (PA) 亚型,其特征是瘤生长和异常的生长激素 (GH) 分泌.
- Rac GTPase激活蛋白1 (RACGAP1) 与各种癌症有关,但其在GHPA中的作用尚不清楚.
研究的目的:
- 研究RACGAP1在GHPA中的表达和功能作用.
- 为了确定潜在的治疗抑制剂,针对RACGAP1进行GHPA治疗.
主要方法:
- 免疫组织化学评估RACGAP1在GHPA和正常组织中的表达.
- 在体外 (GH3细胞) 和体内 (异种移植模型) 实验中,评估RACGAP1敲击对瘤进展的影响.
- RNA测序,生物信息学分析和西班牙血迹,以阐明下游机制.
- 虚拟查和生物化学测试以识别和验证RACGAP1抑制剂.
主要成果:
- 与正常的垂体组织相比,GHPA中RACGAP1的表达显著升高.
- 在体外和体内,RACGAP1的敲击抑制了GHPA细胞增殖和瘤生长.
- 抑制RACGAP1导致p21细胞周期基因的上调和下调 (环A,CDK1,CDK2).
- DB07268被确定为一种强大的RACGAP1抑制剂,有效抑制GH3细胞增殖.
结论:
- 在GHPA的发展和进展中,RACGAP1是关键因素.
- 已识别的抑制剂,DB07268,显示出作为GHPA的新治疗策略的希望.
相关概念视频
01:24Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:22Activation and Inactivation of G Proteins
6.8K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.8K